Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | December 15, 2011

Mammography’s Looming Dose War

By Greg Freiherr

As the dose wars in computed tomography (CT) draw to a close, a new one approaches, this one in mammography. The surprise should not be that this war is coming, but that it is taking so long to get here.

Mammography is the only imaging exam widely performed to screen apparently healthy people. It exposes them to ionizing radiation that, if administered in substantial quantities, can cause the very disease for which they are being screened. And it does so not once or twice, but annually for 30 or more years, per guidelines developed by the American Cancer Society (http://www.cancer.org/Healthy/FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer), with the understanding that the risk of cancer from radiation exposure increases with cumulative dose.

Yet, in the past, when questions about the benefit of such repetitive screening were raised, they were immediately and soundly rebuked by women’s health leaders who defended screening as a major, if not the primary, reason for declining deaths due to breast cancer.  Then why now do I believe dose will become an issue? Because the technology to reduce dose is finally available in the United States  – and being aggressively marketed on its ability to significantly cut patient radiation dose.

This product – Philips’ Microdose mammography product – like so much about mammography and radiation dose, is steeped in irony. It is not new.  It has been sold for years in Europe. But Microdose entered the U.S. only this fall after Philips Healthcare acquired Sectra’s mammography modality business operations.

Three months after this deal was final, during the RSNA annual meeting in November, the ability of this product to cut patient radiation dose was ballyhooed on the exhibit floor of the McCormick Center, on television, even on the sides of buses ferrying radiologists to and from the meeting. The message was inescapable. And it will become so again in the year ahead.

Much like what happened in CT, all the vendors of mammography equipment will have to climb onboard this bandwagon and they will have to do so quickly. They cannot cede the high ground of digital mammography to newcomer Philips, nor can they risk appearing unsympathetic to concerns about radiation dose, when tens of millions of American women undergo mammography every year.

With this, we can expect a new vernacular for the modality, one reliant on the use of “low,” “optimized,” “minimum” and “efficient” as  descriptors of dose administered by mammography equipment. Vendors will use several, possibly all, these descriptors in the same paragraph, if not the same sentence to define their products.

When that happens, it will be a sure sign that this new war has begun.

Related Content

News | Breast Imaging | December 09, 2016
In the largest-ever study on screening mammography outcomes, researchers found that there is no clear cut-off age to...
Numa, NumaStatus, radiation dose reporting software, RSNA 2016
News | Radiation Dose Management | December 08, 2016
Numa introduced a new software application at the 2016 Annual Meeting of the Radiological Society of North America (...
Technology | Computer-Aided Detection Software | December 07, 2016
QView Medical Inc. announced that it received U.S. Food and Drug Administration (FDA) approval in early November for...
Ikonopedia, Closed-Loop Resolution Manager, breast imaging, reporting, RSNA 2016
News | Breast Imaging | December 07, 2016
Ikonopedia showcased its new Closed-Loop Resolution Manager, designed to keep breast imaging patients from falling...
tomosynthesis, early detection, breast cancer, Solis Mammography, Stephen Rose, RSNA 2016
News | Breast Imaging | December 02, 2016
New research presented at the 2016 Radiological Society of North America (RSNA) annual meeting found recall rates,...
Volpara Solutions, VolparaEnterprise 2.0, breast imaging software, RSNA 2016
News | Breast Imaging | December 02, 2016
Volpara Solutions announced the launch of VolparaEnterprise 2.0 software, which helps breast imaging providers deliver...
mammography, age cut-off, clinical study, RSNA 2016, Cindy Lee
News | Mammography | November 28, 2016
In the largest-ever study on screening mammography outcomes, researchers found that there is no clear cut-off age to...
Dilon Diagnostics, GE Healthcare, RSNA 2016, Discovery NM750b molecular breast imaging system, biopsy accessory, FDA clearance
Technology | Breast Imaging | November 28, 2016
November 28, 2016 — Dilon Diagnostics and GE Healthcare announced the U.S.
Ambra Health, Radxx, RAD Women, female radiologists, ACR, Geraldine McGinty, RSNA 2016
News | Business | November 23, 2016
Ambra Health announced it will launch RAD Women (#RADxx), an initiative focused on fostering networking and mentorship...
Overlay Init